Biotechnology Assets S.A. (BST) — Cash Flow Reinvestment Rate
Biotechnology Assets S.A. (BST) has a Cash Flow Reinvestment Rate of 0.00x as of June 2025, reinvesting €1.99K (capex €1.99K ) from operating cash flow of €658.13K. See Biotechnology Assets S.A. (BST) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Biotechnology Assets S.A. Cash Flow Reinvestment Rate (2015–2023)
Historical reinvestment intensity for Biotechnology Assets S.A. across 5 annual periods. For the full cash flow conversion analysis, see Biotechnology Assets S.A. cash flow conversion.
Annual Cash Flow Reinvestment Rate for Biotechnology Assets S.A. (2015–2023)
Year-by-year capital reinvestment analysis for Biotechnology Assets S.A.. See how financially flexible is Biotechnology Assets S.A. to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 6.83x | €325.97K | €47.74K | €325.97K | ▲ +15235.3% |
| 2020 | 0.04x | €391.53K | €8.79 Million | €391.53K | ▼ -99.4% |
| 2017 | 7.33x | €1.56 Million | €213.49K | €1.56 Million | ▲ +508.5% |
| 2016 | 1.20x | €3.27 Million | €2.71 Million | €3.27 Million | ▼ -82.2% |
| 2015 | 6.75x | €1.07 Million | €158.16K | €1.07 Million | — |